Epilepsy Clinical Trial
Official title:
Flexible Representation of Speech in the Supratemporal Plane
The overarching goal of this exploratory research is to understand the dynamic and flexible nature of speech processing in the human supratemporal plane. The temporal lobe has long been established as a region of interest in the speech perception and processing literature because it contains the auditory cortex. More recently, research has localized the supratemporal plane as an area that exhibits response specificity to acoustic properties of complex auditory signals like speech. The supratemporal plane, comprised of Heschl's gyrus, the planum polare, and the planum temporale, is capable of the rapid spectrotemporal analysis required to map acoustic information to linguistic representation. Neural activity in this area, however, is rarely studied directly because it is difficult to access with non-invasive measures like scalp electroencephalography (EEG). Capitalizing on the unique opportunity to access these areas via routine clinical stereoelectroencephalography (sEEG) in a patient population, this study seeks to understand how cortical responses reflect the diagnosticity of two acoustic-phonetic dimensions of interest and how responses rapidly and flexibly adapt to changes in listening demands. Examining how neural response to voice onset time (VOT) and fundamental frequency (F0) modulates as a function of perceptual weight carried in signaling phoneme categories, and identifying how changes in listening context shift perceptual weight, will provide invaluable data that indicates how speech processing flexibly adapts to short-term acoustic patterns.
Status | Recruiting |
Enrollment | 25 |
Est. completion date | December 2024 |
Est. primary completion date | December 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 25 Years |
Eligibility | Inclusion Criteria: - Individuals 15-25 years old - Undergoing sEEG placement in the supratemporal plane for clinically necessary localization of epileptic foci or language mapping - Fluent English speakers - Cognition and speech-language skills within normal limits (as determined by evaluation prior to surgery) - Normal or correct-to-normal visual acuity - Normal hearing acuity in each ear (as determined by audiometric assessment) - No history of autism or ADHD Exclusion Criteria: - Individuals with intellectual disabilities - Abnormal epileptiform activity in the supratemporal plane - Lack of fluent English comprehension/production - Severe language or auditory-specific cognitive dysfunction - History of autism or ADHD |
Country | Name | City | State |
---|---|---|---|
United States | UPMC Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh | Carnegie Mellon University, National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Supratemporal Neural Response to Change in Acoustic-Phonetic Dimensions | Neural activity will be measured via simultaneous EEG-sEEG monitoring in the supratemporal plane as indicated by high-gamma band activity in the electrical signal. Neural activity will be measured as participants listen to acoustic stimuli with gradually manipulated acoustic dimensions, fundamental frequency (F0) and voice onset time (VOT). | During sEEG-EEG recording sessions, up to 3 hours total | |
Primary | Behavioral Impact of Change in Acoustic-Phonetic Dimensions | Behavioral responses in the form of a category judgment will be obtained as participants listen to acoustic stimuli in with gradually varying fundamental frequency (F0) and voice onset time (VOT). Participants will provide a behavioral response by indicating the phoneme perceived at the beginning of stimulus words (/b/ or /p/). | During sEEG-EEG recording sessions, up to 3 hours total | |
Primary | Supratemporal Neural Response to Change in Listening Context | Neural activity will be measured via simultaneous EEG-sEEG monitoring in the supratemporal plane as indicated by high-gamma band activity in the electrical signal. Neural activity will be measured as participants listen to acoustic stimuli in two listening contexts: speech-in-noise and accented speech. | During sEEG-EEG recording sessions, up to 3 hours total | |
Primary | Behavioral Impact of Change in Listening Context | Behavioral responses in the form of a category judgment will be obtained as participants listen to acoustic stimuli in two different listening contexts: speech-in-noise and accented speech. Participants will provide a behavioral response by indicating the phoneme perceived at the beginning of stimulus words (/b/ or /p/). | During sEEG-EEG recording sessions, up to 3 hours total | |
Secondary | Neural Response of Non-Regions of Interest to Change in Acoustic-Dimension | Neural activity will be measured via simultaneous EEG-sEEG monitoring of cortical regions outside the supratemporal plane as indicated by high-gamma band activity in the electrical signal. Neural activity will be measured as participants listen to acoustic stimuli with gradually manipulated acoustic dimensions, fundamental frequency (F0) and voice onset time (VOT). | During sEEG-EEG recording sessions, up to 3 hours total | |
Secondary | Neural Response of Non-Regions of Interest to Change in Listening Context | Neural activity will be measured via simultaneous EEG-sEEG monitoring in cortical regions outside the supratemporal plane as indicated by high-gamma band activity in the electrical signal. Neural activity will be measured as participants listen to acoustic stimuli in two listening contexts: speech-in-noise and accented speech. | During sEEG-EEG recording sessions, up to 3 hours total |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A |